Impact of the phased abolition of co‐payments on the utilisation of selected prescription medicines in Wales

• Published in: Health economics Vol. 27; no. 1; pp. 236 - 243
• Main Authors: Alam, M. Fasihul, Cohen, David, Dunstan, Frank, Hughes, Dyfrig, Routledge, Philip
• Format: Journal Article
• Language: English
• Published: England Wiley Periodicals Inc 01.01.2018
• Subjects: Cost Sharing - economics; co‐payment; difference‐in‐difference; dispensing; Drugs; England; General practice; Health care expenditures; Health economics; Humans; Insurance, Pharmaceutical Services - economics; Models, Econometric; Payments; Prescription drugs; Prescription Drugs - economics; Price elasticity; Socioeconomic factors; Wales; England; Wales; United Kingdom > UK; dispensing; co-payment; difference-in-difference; price-elasticity

We have taken advantage of a natural experiment to measure the impact of the phased abolition of prescription co‐payments in Wales. We investigated 3 study periods covering the phased abolition: from £6 to £4, £4 to £3, and £3 to £0. A difference‐in‐difference modelling was adopted and applied to mo...